[Control of the paroxysms of supraventricular tachycardia at the pre-hospital stage: finoptin or adenosine triphosphate?].
Varshavskiĭ
S Iu
SIu
Medvedev
M M
MM
D000255:Adenosine Triphosphate / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005392:First Aid; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000503:physiopathology; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000503:physiopathology; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use*
D000255:Adenosine Triphosphate; D014700:Verapamil
Kupirovanie pristupov supraventrikuliarnykh takhikardiĭ na dogospital'nom étape: finoptin ili adenozintriofosfat?